Cash and Cash Equivalents, at Carrying Value of Can-Fite BioPharma Ltd. from 31 Dec 2016 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Can-Fite BioPharma Ltd. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Dec 2016 to 30 Jun 2025.
  • Can-Fite BioPharma Ltd. Cash and Cash Equivalents, at Carrying Value for the quarter ending 30 Jun 2025 was $6,454,000, a 37% increase year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $6,454,000 +$1,735,000 +37% 30 Jun 2025 6-K 28 Aug 2025 2025 Q2
Q4 2024 $4,825,000 +$547,000 +13% 31 Dec 2024 6-K 28 Aug 2025 2025 Q2
Q2 2024 $4,719,000 30 Jun 2024 6-K 29 Aug 2024 2024 Q2
Q4 2023 $4,278,000 +$1,300,000 +44% 31 Dec 2023 20-F 14 Apr 2025 2024 FY
Q4 2022 $2,978,000 -$1,412,000 -32% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q4 2021 $4,390,000 -$3,878,000 -47% 31 Dec 2021 20-F 30 Mar 2023 2022 FY
Q2 2021 $7,537,000 -$1,522,000 -17% 30 Jun 2021 6-K 26 Aug 2021 2021 Q2
Q4 2020 $8,268,000 +$5,571,000 +207% 31 Dec 2020 20-F 24 Mar 2022 2021 FY
Q2 2020 $9,059,000 +$857,000 +10% 30 Jun 2020 6-K 26 Aug 2021 2021 Q2
Q4 2019 $2,697,000 -$918,000 -25% 31 Dec 2019 6-K 26 Aug 2021 2021 Q2
Q2 2019 $8,202,000 30 Jun 2019 6-K 27 Aug 2020 2020 Q2
Q4 2018 $3,615,000 +$110,000 +3.1% 31 Dec 2018 20-F 25 Mar 2021 2020 FY
Q4 2017 $3,505,000 -$4,610,000 -57% 31 Dec 2017 20-F 25 Mar 2021 2020 FY
Q4 2016 $8,115,000 31 Dec 2016 6-K 01 Jun 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.